指南与共识呼吸衰竭与机械通气重症综合管理与镇静镇痛

德国成人医院获得性肺炎指南2024更新版核心推荐摘要

Key summary of German national guideline for adult patients with nosocomial pneumonia- Update 2024 Funding number at the Federal Joint Committee (G-BA): 01VSF22007.
指南 / 共识 · Infection · 2024-08-08
一句话结论德国指南2024更新:医院获得性肺炎应按多重耐药菌和铜绿假单胞菌风险分层治疗,仅感染性休克且合并额外MDRP风险因素者才用经验性联合治疗,疗程建议7–8天。

本文为德国成人医院获得性肺炎指南2024更新版的执行摘要,采用GRADE证据到决策框架系统评估文献,由跨学科专家组共识形成推荐。原指南共26条推荐,其中13条基于系统评价和/或Meta分析,13条为专家共识;本摘要呈现11条最 relevant 的日常临床实践推荐,其中2条专家共识、9条基于证据(4条强推荐、5条弱推荐、2条开放性推荐)。核心内容包括按多重耐药病原体和/或铜绿假单胞菌风险因素分层管理、不常规使用细菌多重PCR、支气管镜采样不优于非支气管镜采样、仅感染性休克且存在额外MDRP风险因素者接受经验性联合治疗、临床稳定后降阶梯并聚焦治疗、危重症患者优选延长输注适宜β-内酰胺类抗生素、疗程建议7–8天、PCT算法可能缩短抗生素疗程、ICU患者应行支气管灌洗液抗原检测诊断侵袭性肺曲霉病。

要点

  • 医院获得性肺炎患者应分为有和无多重耐药病原体和/或铜绿假单胞菌风险因素两类进行管理。
  • 仅感染性休克且存在额外多重耐药病原体风险因素的患者才应接受经验性联合治疗。
  • 临床稳定的患者应降阶梯并聚焦抗生素治疗;危重症患者优选延长输注适宜β-内酰胺类抗生素。
  • 疗程建议7–8天;基于降钙素原(PCT)的算法可能用于缩短抗生素治疗疗程。
  • ICU患者存在侵袭性肺曲霉病(IPA)风险,应使用支气管灌洗液抗原检测诊断曲霉。

适用人群与场景

  • 成人医院获得性肺炎患者(德国指南,聚焦德国流行病学和诊疗标准)。

处置流程与药物剂量

  • 管理医院获得性肺炎患者时,应将患者分为有和无多重耐药病原体和/或铜绿假单胞菌风险因素两类。
  • 不常规使用细菌多重聚合酶链反应(PCR)。
  • 支气管镜诊断在主要结局方面不优于非支气管镜采样。
  • 仅感染性休克且存在额外多重耐药病原体(MDRP)风险因素的患者应接受经验性联合治疗。
  • 临床稳定的患者应降阶梯并聚焦抗生素治疗。
  • 危重症患者优选延长输注适宜的β-内酰胺类抗生素。
  • 疗程建议7–8天。
  • 基于降钙素原(PCT)的算法可能用于缩短抗生素治疗疗程。

研究设计与关键结果

  • 原指南含26条成人医院获得性肺炎诊断和治疗推荐,其中13条基于系统评价和/或Meta分析,13条为共识专家意见。
  • 本核心摘要呈现11条最相关于日常临床实践的推荐,其中2条为专家共识,9条基于证据(4条强推荐、5条弱推荐、2条开放性推荐)。

证据类型、等级与局限

  • 指南采用系统评估和决策过程,使用证据到决策框架(GRADE);推荐由跨学科专家组共识形成;证据分析和解读由德国创新基金支持,由独立方法学家进行广泛文献检索和(Meta)分析。
  • 局限:原文未报告局限性

对床旁实践的改变

  • 对医院获得性肺炎患者应先按多重耐药病原体和/或铜绿假单胞菌风险因素分层,再决定经验性治疗策略。
  • 不应常规送检细菌多重PCR;支气管镜采样在主要结局上不优于非支气管镜采样。
  • 经验性联合治疗仅限感染性休克且存在额外MDRP风险因素的患者;临床稳定后应降阶梯并聚焦治疗。
  • 危重症患者使用适宜β-内酰胺类抗生素时优选延长输注;疗程7–8天,PCT算法可能缩短疗程。
  • ICU患者需警惕侵袭性肺曲霉病,诊断应使用支气管灌洗液抗原检测。

指南或共识出处

  • 德国成人医院获得性肺炎指南2024更新版(German national guideline for adult patients with nosocomial pneumonia - Update 2024),联邦联合委员会(G-BA)资助编号01VSF22007。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

PURPOSE: This executive summary of a German national guideline aims to provide the most relevant evidence-based recommendations on the diagnosis and treatment of nosocomial pneumonia.

METHODS: The guideline made use of a systematic assessment and decision process using evidence to decision framework (GRADE). Recommendations were consented by an interdisciplinary panel. Evidence analysis and interpretation was supported by the German innovation fund providing extensive literature searches and (meta-) analyses by an independent methodologist. For this executive summary, selected key recommendations are presented including the quality of evidence and rationale for the level of recommendation.

RESULTS: The original guideline contains 26 recommendations for the diagnosis and treatment of adults with nosocomial pneumonia, thirteen of which are based on systematic review and/or meta-analysis, while the other 13 represent consensus expert opinion. For this key summary, we present 11 most relevant for everyday clinical practice key recommendations with evidence overview and rationale, of which two are expert consensus and 9 evidence-based (4 strong, 5 weak and 2 open recommendations). For the management of nosocomial pneumonia patients should be divided in those with and without risk factors for multidrug-resistant pathogens and/or Pseudomonas aeruginosa. Bacterial multiplex-polymerase chain reaction (PCR) should not be used routinely. Bronchoscopic diagnosis is not considered superior to´non-bronchoscopic sampling in terms of main outcomes. Only patients with septic shock and the presence of an additional risk factor for multidrug-resistant pathogens (MDRP) should receive empiric combination therapy. In clinically stabilized patients, antibiotic therapy should be de-escalated and focused. In critically ill patients, prolonged application of suitable beta-lactam antibiotics should be preferred. Therapy duration is suggested for 7-8 days. Procalcitonin (PCT) based algorithm might be used to shorten the duration of antibiotic treatment. Patients on the intensive care unit (ICU) are at risk for invasive pulmonary aspergillosis (IPA). Diagnostics for Aspergillus should be performed with an antigen test from bronchial lavage fluid.

CONCLUSION: The current guideline focuses on German epidemiology and standards of care. It should be a guide for the current treatment and management of nosocomial pneumonia in Germany.

来源:Infection,查看原文。版权归原作者所有。

参考来源

  1. Rademacher J, Ewig S, Grabein B, et al. Key summary of German national guideline for adult patients with nosocomial pneumonia- Update 2024 Funding number at the Federal Joint Committee (G-BA): 01VSF22007. Infection. 2024. PMID: 39115698. doi:10.1007/s15010-024-02358-y

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。